Activation of Immune Response in Disease Dynamics via Controlled Drug Scheduling

被引:18
作者
Chang, Hyeygjeon [1 ]
Astolfi, Alessandro [1 ,2 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, London, England
[2] Univ Roma Tor Vergata, Dipartimento Informat Sistemi & Prod, I-00133 Rome, Italy
关键词
Biological systems; disease dynamics; human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) models; long-term nonprogressor; HIV-INFECTION; MULTIDRUG THERAPIES; HIV/AIDS; MODEL;
D O I
10.1109/TASE.2008.2008156
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
The human immunodeficiency virus (HIV) infection, that causes acquired immune deficiency syndrome (AIDS), is a dynamic process that can be modeled via differential equations. The primary goal of this paper is to introduce a control philosophy to boost the response of the immune system by means of drug scheduling. The control purpose is to steer the system to an equilibrium condition known as long-term nonprogressor, which corresponds to an infected patient that does not develop the symptoms of AIDS. The feasibility of the control methodology is illustrated via simulations on two HIV dynamic models and on a general disease model.
引用
收藏
页码:248 / 255
页数:8
相关论文
共 43 条
[1]   HIV dynamics: Modeling, data analysis, and optimal treatment protocols [J].
Adams, BM ;
Banks, HT ;
Davidian, M ;
Kwon, HD ;
Tran, HT ;
Wynne, SN ;
Rosenberg, ES .
JOURNAL OF COMPUTATIONAL AND APPLIED MATHEMATICS, 2005, 184 (01) :10-49
[2]  
Adams BM, 2004, MATH BIOSCI ENG, V1, P223
[3]  
ALCORN K, 1999, HIV AIDS TREATMENTS
[4]   Effector cytotoxic T lymphocyte numbers induced by vaccination should exceed levels in chronic infection for protection from HIV [J].
Altes, HK ;
Price, DA ;
Jansen, VAA .
VACCINE, 2001, 20 (1-2) :3-6
[5]  
[Anonymous], 1994, DIS DYNAMICS
[6]  
[Anonymous], 2000, VIRUS DYNAMICS
[7]   A state-dependent Riccati equation-based estimator approach for HIV feedback control [J].
Banks, HT ;
Kwon, HD ;
Toivanen, JA ;
Tran, HT .
OPTIMAL CONTROL APPLICATIONS & METHODS, 2006, 27 (02) :93-121
[8]   A tale of two futures: HIV and antiretroviral therapy in San Francisco [J].
Blower, SM ;
Gershengorn, HB ;
Grant, RM .
SCIENCE, 2000, 287 (5453) :650-654
[9]   Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection [J].
Bonhoeffer, S ;
Rembiszewski, M ;
Ortiz, GM ;
Nixon, DF .
AIDS, 2000, 14 (15) :2313-2322
[10]   Feedback control of a biodynamical model of HIV-1 [J].
Brandt, ME ;
Chen, GR .
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2001, 48 (07) :754-759